Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 24, 2014Journal of Child and Adolescent PsychopharmacologyOpen Access

Body Mass Index Change in Autism Spectrum Disorders: Comparison of Treatment with Risperidone and Aripiprazole

View Full Paper
Ask AI
Bookmark
Share

Authors

LWLogan WinkMEMaureen EarlyTSTori L. Schaefer

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wink et al. (2014) studied this question.

synapsesocial.com/papers/6a7104cea528af2d65c3dd89https://doi.org/10.1089/cap.2013.0099
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Double-blind, Placebo-Controlled Study of Risperidone in Adults With Autistic Disorder and Other Pervasive Developmental Disorders1998 · 430 citations
  2. 2Aripiprazole, an Antipsychotic With a Novel Mechanism of Action, and Risperidone vs Placebo in Patients With Schizophrenia and Schizoaffective Disorder2003 · 595 citations
  3. 3The Role of Psychosocial Interventions in Bipolar II Disorder2008 · 108 citations
  4. 4Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents2009 · 1,040 citations
  5. 5Risperidone in the Treatment of Disruptive Behavioral Symptoms in Children With Autistic and Other Pervasive Developmental Disorders2004 · 567 citations